Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

1.

Estimation of utilities for chronic hepatitis C from SF-36 scores.

Thein HH, Krahn M, Kaldor JM, Dore GJ.

Am J Gastroenterol. 2005 Mar;100(3):643-51.

PMID:
15743364
[PubMed - indexed for MEDLINE]
2.

Health-state utilities in liver disease: a systematic review.

McLernon DJ, Dillon J, Donnan PT.

Med Decis Making. 2008 Jul-Aug;28(4):582-92. doi: 10.1177/0272989X08315240. Epub 2008 Apr 18. Review.

PMID:
18424560
[PubMed - indexed for MEDLINE]
3.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

PMID:
16959170
[PubMed - indexed for MEDLINE]
Free Article
4.

Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment.

Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F.

Hepatology. 2005 Apr;41(4):790-800. Review.

PMID:
15791608
[PubMed - indexed for MEDLINE]
5.

Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy.

Omata M, Yoshida H, Shiratori Y.

Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S141-3. Review.

PMID:
16234063
[PubMed - indexed for MEDLINE]
6.

Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms.

Gordon CE, Uhlig K, Lau J, Schmid CH, Levey AS, Wong JB.

Am J Kidney Dis. 2008 Feb;51(2):263-77. doi: 10.1053/j.ajkd.2007.11.003. Review.

PMID:
18215704
[PubMed - indexed for MEDLINE]
7.
8.

A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.

Connock M, Juarez-Garcia A, Frew E, Mans A, Dretzke J, Fry-Smith A, Moore D.

Health Technol Assess. 2006 Jun;10(20):iii-iv, ix-113. Review.

PMID:
16729919
[PubMed - indexed for MEDLINE]
Free Article
9.

Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial).

Michaels JA, Campbell WB, Brazier JE, Macintyre JB, Palfreyman SJ, Ratcliffe J, Rigby K.

Health Technol Assess. 2006 Apr;10(13):1-196, iii-iv. Review.

PMID:
16707070
[PubMed - indexed for MEDLINE]
Free Article
10.

Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review.

Räsänen P, Roine E, Sintonen H, Semberg-Konttinen V, Ryynänen OP, Roine R.

Int J Technol Assess Health Care. 2006 Spring;22(2):235-41. Review.

PMID:
16571199
[PubMed - indexed for MEDLINE]
11.

Overview of research on health-related quality of life in patients with chronic liver disease.

Gutteling JJ, de Man RA, Busschbach JJ, Darlington AS.

Neth J Med. 2007 Jul-Aug;65(7):227-34. Review.

PMID:
17656809
[PubMed - indexed for MEDLINE]
Free Article
12.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

PMID:
16904046
[PubMed - indexed for MEDLINE]
Free Article
13.

The utility of health states after stroke: a systematic review of the literature.

Post PN, Stiggelbout AM, Wakker PP.

Stroke. 2001 Jun;32(6):1425-9. Review.

PMID:
11387509
[PubMed - indexed for MEDLINE]
Free Article
14.

Hepatitis C virus in Asia: utility values based on the Short Form-36 questionnaire.

Crawford B, Yeung CK, Tanaka E, Kraemer M, Leteneux C.

Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):765-73. doi: 10.1586/erp.12.61. Review.

PMID:
23252358
[PubMed - indexed for MEDLINE]
15.

Economic burden of hepatitis C-associated diseases: Europe, Asia Pacific, and the Americas.

El Khoury AC, Wallace C, Klimack WK, Razavi H.

J Med Econ. 2012;15(5):887-96. doi: 10.3111/13696998.2012.681332. Epub 2012 May 24. Review.

PMID:
22458755
[PubMed - indexed for MEDLINE]
16.

[Significance of health related quality of life in assessing curative effect for chronic hepatitis C].

Jin CH, Yao GB.

Zhonghua Gan Zang Bing Za Zhi. 2004 Mar;12(3):190-2. Review. Chinese. No abstract available.

PMID:
15059317
[PubMed - indexed for MEDLINE]
17.

Quality of life and cognitive function in chronic hepatitis C - what to measure?

Forton DM, Thomas HC, Taylor-Robinson SD.

J Hepatol. 2003 Aug;39(2):272-4. Review. No abstract available.

PMID:
12873826
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk